Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Menin-MLL inhibitor MI-2

Copy Product Info
😃Good
Catalog No. T2649Cas No. 1271738-62-5
Alias MI-2, MI2, MI 2, Menin-MLL inhibitor 2, Menin-MLL Inhibitor

Menin-MLL inhibitor MI-2 (MI2) is a potent menin-MLL interaction inhibitor with IC50 of 446 nM.

Menin-MLL inhibitor MI-2

Menin-MLL inhibitor MI-2

Copy Product Info
😃Good
Purity: 97.46%
Catalog No. T2649Alias MI-2, MI2, MI 2, Menin-MLL inhibitor 2, Menin-MLL InhibitorCas No. 1271738-62-5
Menin-MLL inhibitor MI-2 (MI2) is a potent menin-MLL interaction inhibitor with IC50 of 446 nM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$35In StockIn Stock
5 mg$56In StockIn Stock
10 mg$81In StockIn Stock
25 mg$172In StockIn Stock
50 mg$255In StockIn Stock
100 mg$396In StockIn Stock
200 mg$579InquiryInquiry
1 mL x 10 mM (in DMSO)$62In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.46%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Menin-MLL inhibitor MI-2 (MI2) is a potent menin-MLL interaction inhibitor with IC50 of 446 nM.
Targets&IC50
Menin-MLL:446 nM
In vivo
MI-2 effectively inhibits cell proliferation and induces apoptosis in human MLL leukemia cell lines bearing various MLL translocations. In HEK293 cells, MI-2 penetrates its protein target, efficiently inhibiting the interaction between menin and MLL-AF9. By downregulating the expression of target genes essential for the oncogenic activity of MLL fusion proteins, MI-2 effectively blocks leukemia transformation mediated by MLL fusion proteins.
Kinase Assay
High Throughput Screening: FITC-MBM1 at 15 nM and menin at 150 nM in the FP buffer are mixed and incubated for 1h in the dark at room temperature. For point screening, the 0.2 μL of each compound (20 μM final concentration, 1% DMSO) is added to 20 μL of the aliquot of the protein-peptide mixture and incubated on 384-well plates in the dark at room temperature for 1h. In confirmation screening, the serial dilution plates with compounds in DMSO are prepared and used to titrate the menin-FITC-MBM1 complex. Change in fluorescence polarization is monitored at 525 nm after excitations at 495 nm using the PHERAstar microplate reader (BMG) and applied to determine IC50 values with the Origin 7.0 program.
Cell Research
The MLL-AF9 and E2A-HLF transduced murine BMC are plated in 12-well plates at the concentration of 5×103 cells/mL with 1 mL methylcellulose medium M3234 containing 20% IMDM medium, 1% penicillin/streptomycin, IL-3 and 0.25% DMSO or compounds. 6 days later colonies are stained with 100 μL iodonitrotetrazolium chloride at final concentration of 1 mg/mL, incubated at 37°C for 30 min and counted. To replate for the 2nd round, colonies are counted at day 6 without staining and cells were washed out by 1×PBS buffer and resuspended in IMDM medium containing 15% FBS, 1% penicillin/streptomycin and IL-3. 5×103 cells are plated in 12-well plates with 1ml methycellulose medium M3234 containing 20% IMDM medium, 1% penicillin/streptomycin, IL-3 and 0.25% DMSO or compounds. 6 days later colonies are stained and counted.(Only for Reference)
SynonymsMI-2, MI2, MI 2, Menin-MLL inhibitor 2, Menin-MLL Inhibitor
Chemical Properties
Molecular Weight375.55
FormulaC18H25N5S2
Cas No.1271738-62-5
SmilesCCCc1cc2c(ncnc2s1)N1CCN(CC1)C1=NCC(C)(C)S1
Relative Density.no data available
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 70 mg/mL (186.39 mM), Sonication is recommended.
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 70 mg/mL (186.39 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.33 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO/Ethanol
1mg5mg10mg50mg
1 mM2.6628 mL13.3138 mL26.6276 mL133.1381 mL
5 mM0.5326 mL2.6628 mL5.3255 mL26.6276 mL
10 mM0.2663 mL1.3314 mL2.6628 mL13.3138 mL
20 mM0.1331 mL0.6657 mL1.3314 mL6.6569 mL
50 mM0.0533 mL0.2663 mL0.5326 mL2.6628 mL
100 mM0.0266 mL0.1331 mL0.2663 mL1.3314 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Menin-MLL inhibitor MI-2 | purchase Menin-MLL inhibitor MI-2 | Menin-MLL inhibitor MI-2 cost | order Menin-MLL inhibitor MI-2 | Menin-MLL inhibitor MI-2 chemical structure | Menin-MLL inhibitor MI-2 in vivo | Menin-MLL inhibitor MI-2 formula | Menin-MLL inhibitor MI-2 molecular weight